FDA Approves New Blood Test for Alzheimer's | Amarillo News

FDA just approved a new blood test for Alzheimer’s — the fourth in under two years — from Roche, designed to help doctors diagnose potential cases in people over 55 experiencing memory issues. This breakthrough, developed with Eli Lilly, offers a faster, clearer diagnostic tool compared to traditional brain scans and multi-step evaluations. The Elecsys Phospho-Tau test is the first FDA-cleared blood test that can both confirm and rule out key Alzheimer’s markers, giving clinicians more confidence during routine or specialist visits. While experts stress no single test is a cure-all, this advancement marks real progress in making Alzheimer’s diagnosis more accessible and efficient for patients navigating cognitive decline. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8ec659cb8a1f9726